Corpus Intelligence EBITDA Bridge — N. OAKS REHABILITATION HOSPITAL 2026-04-27 01:01 UTC
EBITDA Bridge — N. OAKS REHABILITATION HOSPITAL
CCN 193044 | LA | 27 beds | Current EBITDA $5.7M → Pro Forma $6.3M (+$523K)
🛡️ Public data only — no PHI permitted on this instance.
EBITDA BRIDGE  ·  CCN 193044

N. OAKS REHABILITATION HOSPITAL
value-creation walk.

7-lever RCM bridge from current EBITDA to pro-forma — denial / underpay / DAR / coding / contract / cost discipline / cash acceleration. Each lever shows current vs benchmark target with data provenance.

$9.8M
Net Revenue HCRIS
$5.7M
Current EBITDA COMPUTED
+$523K
RCM EBITDA Uplift
$6.3M
Pro Forma EBITDA
+532bps
Margin Improvement
$377K
WC Released (1x)

Bridge Realization Estimate

ML model predicts what fraction of the bridge is achievable (accuracy: 60%, n=5,839)

68%
Realization (C)
$523K
Modeled Uplift
$358K
Risk-Adjusted
-$165K
Execution Discount
Revenue per BedLower Revenue per Bed reduces execution likelihood
Bed CountHigher Bed Count increases execution likelihood
Occupancy RateHigher Occupancy Rate increases execution likeliho
Commercial Payer %Commercial Payer % has minimal effect on execution
Net-to-Gross RatioNet-to-Gross Ratio has minimal effect on execution

Expected realization: 68% of modeled bridge. Strengths: Bed Count, Occupancy Rate. Risks: Revenue per Bed. Risk-adjusted uplift: $0.4M (vs $0.5M modeled).

EBITDA Bridge — 7 RCM Levers

Each bar shows the annual EBITDA impact at full run-rate. Revenue levers increase top-line; cost levers reduce operating expense; cash acceleration releases working capital. Calibrated to published research bands (Denial 12%→5% = $8-15M on $400M NPR).

Denial Rate Reduction
Revenue | 12mo ramp
$198K
+201bp
Cost to Collect
Cost Savings | 12mo ramp
$197K
+200bp
A/R Days Reduction
Cash Accel | 9mo ramp
$120K
+122bp
Clean Claim Rate
Cost Savings | 6mo ramp
$10K
+10bp
Total EBITDA Impact$523K

Lever Detail

Each value shows its data source. SELLER = seller data room, DEFAULT = model default, BENCHMARK = P75 peer benchmark.

LeverCurrentTargetRevenueCostEBITDAWCRamp
Denial Rate Reduction12.0% DEFAULT6.5% BENCHMARK$189K$8K$198K$012mo
Cost to Collect4.5% DEFAULT2.5% BENCHMARK$0$197K$197K$012mo
A/R Days Reduction52.00 DEFAULT38.00 BENCHMARK$30K$89K$120K$377K9mo
Clean Claim Rate88.0% DEFAULT96.0% BENCHMARK$0$10K$10K$06mo
Net Collection Rate93.5% DEFAULT58.1% BENCHMARK$0$0$0$018mo
CDI / Case Mix Index135.0% DEFAULT142.0% BENCHMARK$0$0$0$018mo

Implementation Timing Curve

Linear ramp to full run-rate per lever. Month 0 = close date. Partners should expect 60-70% of total uplift realized by month 12.

LeverM0M3M6M9M12M18M24M36
Denial Rate Reduction$0$49K$99K$148K$198K$198K$198K$198K
Cost to Collect$0$49K$98K$148K$197K$197K$197K$197K
A/R Days Reduction$0$40K$80K$120K$120K$120K$120K$120K
Clean Claim Rate$0$5K$10K$10K$10K$10K$10K$10K
Cumulative$0$143K$286K$425K$523K$523K$523K$523K

Returns Sensitivity (IRR / MOIC)

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Green = exceeds 20% IRR hurdle. Amber = 15-20%. Red = below hurdle or loss. RCM uplift of $523K is added at exit.

Entry \ Exit9.0x10.0x11.0x11.5x12.0x
8.0x43% / 5.9x47% / 6.9x51% / 7.9x53% / 8.4x55% / 8.9x
9.0x37% / 4.9x42% / 5.8x46% / 6.7x48% / 7.1x50% / 7.6x
10.0x32% / 4.1x37% / 4.9x42% / 5.7x44% / 6.1x45% / 6.5x
11.0x28% / 3.4x33% / 4.1x37% / 4.9x39% / 5.2x41% / 5.6x
12.0x23% / 2.9x29% / 3.5x33% / 4.2x35% / 4.5x37% / 4.9x

Covenant Headroom (at 10x Entry, 6.5x Max Leverage)

8.5x
Entry Leverage
7.8x
Pro Forma Leverage
-1.3x
Headroom (turns)
-19%
EBITDA Cushion

Pro forma EBITDA can decline -19% before the 6.5x covenant trips. RCM uplift reduces leverage from 8.5x to 7.8x, adding 0.7 turns of cushion.

5-Year Value Creation Waterfall

EBITDA trajectory: 3% organic growth + RCM uplift ramp (full run-rate at month 18).

Base EBITDARCM UpliftTotalMargin
Entry$5.7M$5.7M58.5%
Year 1$5.9M+$349K$6.3M63.8%
Year 2$6.1M+$523K$6.6M67.3%
Year 3$6.3M+$523K$6.8M69.2%
Year 4$6.5M+$523K$7.0M71.1%
Year 5$6.7M+$523K$7.2M73.1%
$57.5M
Entry EV (10x)
$79.1M
Exit EV (11x)
$21.6M
Value Created
$7.2M
Exit EBITDA
$9.2M
Organic Growth
$5.2M
RCM Value Creation
$7.2M
Multiple Expansion

Achievement Sensitivity

What if we only achieve a fraction of each lever? 50% = conservative, 75% = base management case, 100% = plan, 120% = stretch.

Lever50%75%100%120%
Denial Rate Reductio$99K$148K$198K$237K
Cost to Collect$98K$148K$197K$236K
A/R Days Reduction$60K$90K$120K$144K
Clean Claim Rate$5K$7K$10K$12K
Total$262K$393K$523K$628K

Peer Context — Where This Hospital Sits

Key metrics vs 135 size-matched peers. Low percentile on margin/efficiency metrics = more room for improvement = larger bridge opportunity.

MetricHospitalP25P50P75Percentile
Op Margin58.5%-17.2%-3.1%5.9%
P98
Net-to-Gross26.3%32.2%44.2%58.1%
P15
Occupancy55.8%21.1%46.3%68.5%
P60
Rev/Bed$364K$288K$468K$882K
P36
Exp/Bed$151K$276K$468K$963K
P4

Bridge Methodology

Coefficients calibrated to published research bands: denial 12%→5% = $8-15M on $400M NPR. Current metrics estimated from HCRIS public data and ML predictions. Target metrics set at P75 peer benchmarks with 60% gap closure assumption. Revenue levers use NPR × delta × avoidable share. Cost levers use claims volume × cost per reworked claim. Working capital from AR reduction is one-time cash (not included in recurring EBITDA). Returns assume 5.5x leverage, 3% organic growth, 10%/yr debt paydown.

Data: HCRIS FY2022 | 6,123 hospitalsSources: HCRISML